Predictors of Post-COVID-19 Clinical and Cognitive Consequences
VA Office of Research and Development · with John D. Dingell VA Medical Center · NCT06291870
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- January 19, 2023
- Record last updated
- January 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The CDC describes Post-acute sequelae of SARS-COV-2 infection (PASC) for the wide range of physical and mental health consequences experienced by some patients. These sequelae may be present four or more weeks after SARS-COV-2 infection, including patients who had initial mild or asymptomatic acute infection. However, there is complete absence of data whether chronic sleep changes due to COVID-19 infection may influence these physical and mental health consequences. While fatigue is one of the common post-COVID conditions, there are no systematic examinations of sleep disturbances in COVID-19 survivors. This will be a pilot observational retrospective and prospective cohort study, to systematically assess if sleep disturbances and severity of sleep apnea comprise a modifiable facet of PASC as well as the short-term and longer-term effects of COVID-19 infection itself on sleep, cognitive function, exercise capacity and lung function.
Conditions: Post Acute Sequelae of SARS CoV 2 Infection; Obstructive Sleep Apnea
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- All individuals 18 years or older, with prior history of COVID-19 infection diagnosis
- Both genders including all racial and ethnic groups
- Patients with OSA (apnea hypopnea index of 5/hour on polysomnography) with history of COVID-19 infection will be eligible with prior history of COVID-19 infection and without COVID-19 for Aim 2
Exclusion Criteria
- Inability to give consent
- Active suicidal symptoms
- Children of all ages
- Pregnant women
Recruiting US locations
John D. Dingell VA Medical Center, Detroit, MI
Detroit, MI 48201-1916
Site contact: Ruchi Rastogi, MS · 313-576-4464 · ruchi.rastogi@va.gov
Study contacts (from the official record)
- Ruchi Rastogi, MS · (313) 576-4464 · ruchi.rastogi@va.gov
Similar studies in Michigan
All sleep studies in Michigan →- RecruitingHealthy volunteersPhase 1/Phase 2
Sleep Disordered Breathing With Opioid Use
VA Office of Research and Development
- Location
- Detroit, MI
- Eligibility basics
- Ages 18–89
- Recruiting
Janus II Feasibility
Zoll Medical Corporation
- Location
- Wyoming, MI + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Lansing, MI + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
Takeda
- Location
- Lansing, MI + 24 other US sites
- Eligibility basics
- Ages 18–70